Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walther Parson

Showing results (201-210 of 318) with videos related to

Pageof 32
Sort By:
Biological Chemistry|October 28, 2008
Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old ageDietmar Herndler-Brandstetter, Ellen Veel, Gerhard T Laschober, et al.
Molecular Cancer Research : MCR|April 8, 2016
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer CellsFlorian Handle, Holger H H Erb, Birgit Luef, et al.
Forensic Science International. Genetics|May 12, 2023
Special issue: Forensic Genetics: Unde venisti et quo vadis?Manfred Kayser, Antti Sajantila, John M Butler, et al.
Genes|November 3, 2020
Platinum-Quality Mitogenome Haplotypes from United States PopulationsCassandra R Taylor, Kevin M Kiesler, Kimberly Sturk-Andreaggi, et al.
Forensic Science International. Genetics|May 17, 2020
Ethical publication of research on genetics and genomics of biological material: guidelines and recommendationsMaria Eugenia D'Amato, Martin Bodner, John M Butler, et al.
Annals of the New York Academy of Sciences|June 29, 2006
Naive T cells in the elderly: are they still there?Gerald Pfister, Daniela Weiskopf, Lutfan Lazuardi, et al.
The American Journal of Pathology|March 11, 2021
MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP InhibitorsTobias Furlan, Alexander Kirchmair, Natalie Sampson, et al.
Oncotarget|September 13, 2014
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristicsMaximilian Boesch, Alain G Zeimet, Daniel Reimer, et al.
International Journal of Cancer|December 2, 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-responseDaniel Reimer, Maximilian Boesch, Dominik Wolf, et al.
Forensic Science International. Genetics|September 24, 2013
Mass spectrometric base composition profiling: Implications for forensic mtDNA databasingMayra Eduardoff, Gabriela Huber, Birgit Bayer, et al.
Pageof 32

Showing results (201-210 of 318) with videos related to

Sort By:
Pageof 32
Biological Chemistry|October 28, 2008
Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old ageDietmar Herndler-Brandstetter, Ellen Veel, Gerhard T Laschober, et al.
Molecular Cancer Research : MCR|April 8, 2016
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer CellsFlorian Handle, Holger H H Erb, Birgit Luef, et al.
Forensic Science International. Genetics|May 12, 2023
Special issue: Forensic Genetics: Unde venisti et quo vadis?Manfred Kayser, Antti Sajantila, John M Butler, et al.
Genes|November 3, 2020
Platinum-Quality Mitogenome Haplotypes from United States PopulationsCassandra R Taylor, Kevin M Kiesler, Kimberly Sturk-Andreaggi, et al.
Forensic Science International. Genetics|May 17, 2020
Ethical publication of research on genetics and genomics of biological material: guidelines and recommendationsMaria Eugenia D'Amato, Martin Bodner, John M Butler, et al.
Annals of the New York Academy of Sciences|June 29, 2006
Naive T cells in the elderly: are they still there?Gerald Pfister, Daniela Weiskopf, Lutfan Lazuardi, et al.
The American Journal of Pathology|March 11, 2021
MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP InhibitorsTobias Furlan, Alexander Kirchmair, Natalie Sampson, et al.
Oncotarget|September 13, 2014
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristicsMaximilian Boesch, Alain G Zeimet, Daniel Reimer, et al.
International Journal of Cancer|December 2, 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-responseDaniel Reimer, Maximilian Boesch, Dominik Wolf, et al.
Forensic Science International. Genetics|September 24, 2013
Mass spectrometric base composition profiling: Implications for forensic mtDNA databasingMayra Eduardoff, Gabriela Huber, Birgit Bayer, et al.
Pageof 32